Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis.
Susana CoimbraSusana RochaHenrique NascimentoMaria João ValenteCristina CatarinoPetronila Rocha-PereiraMaria Sameiro-FariaJosé Gerardo OliveiraJosé MadureiraJoão Carlos FernandesVasco MirandaLuís BeloElsa Bronze-da-RochaAlice Santos-SilvaPublished in: Clinical kidney journal (2020)
Our data show cfDNA to be a valuable predictive marker of prognosis in ESRD patients on dialysis treatment; high levels of cfDNA were associated with a poor outcome.